Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming conferences:
- American Society for Clinical Oncology (ASCO) 2023 Annual Meeting
- Event Date: June 2-5, Chicago (USA)
- Jefferies Healthcare Conference 2023
- Event Date: June 7-9, New-York (USA)
- Goldman Sachs 44th Annual Global Healthcare Conference
- Event Date: June 12-15, Dana Point (USA)
- Stifel European Healthcare Summit 2023
- Event Date: June 28-30, Bordeaux (France)
| Press Release in English | 314.29 KB |
| Communiqué de presse en français | 144.12 KB |